文献速递肝病消化道肿瘤与早癌

昼夜节律紊乱在人源化小鼠模型中诱导非酒精性脂肪性肝病相关的人肝癌

Circadian dysfunction induces NAFLD-related human liver cancer in a mouse model.
PubMed 文献 · J Hepatol · 2023-10-27

研究利用人源化肝脏小鼠模型,发现慢性昼夜节律紊乱可独立于饮食诱导人肝细胞发生非酒精性脂肪性肝病相关肝细胞癌及转移,转录组与人类非酒精性脂肪性肝炎、肝硬化和肝癌高度相似;稳定节律可降低肝癌发生率并预防转移,特定胆汁酸被鉴定为预后生物标志物。

要点

  • 慢性昼夜节律紊乱可独立于饮食诱导人肝细胞发生NAFLD相关肝癌及转移。
  • 稳定节律同步可降低肝癌发生率并预防肝癌转移。
  • 特定胆汁酸在癌变过程中及节律紊乱时动态变化,可作为预后生物标志物。

核心结论

  • 慢性昼夜节律紊乱对人肝细胞具有独立致癌性。
  • 人源化肝脏小鼠为研究坏死炎症性肝脏环境和神经内分泌昼夜节律紊乱对肝癌发生及抗肝癌治疗的影响提供了有力的临床前模型。

研究设计与样本

  • 研究采用人源化肝脏小鼠模型,对小鼠进行慢性时差诱导,使人类肝细胞自发发生NAFLD相关肝细胞癌。
  • 通过生物标志物、病理/组织学、遗传学、RNA测序、代谢组学和整合生物信息学分析评估该模型的临床相关性。

主要发现

  • 慢性昼夜节律紊乱诱导葡萄糖不耐受、NAFLD相关人肝癌和人肝癌转移,且不依赖于饮食。
  • 坏死炎症性人源化肝脏和肝癌中失调的转录组与人类非酒精性脂肪性肝炎、肝硬化和肝癌的转录组高度相似。
  • 稳定节律同步使宿主节律性地调节NASH和肝癌转录组,降低肝癌发生率并预防肝癌转移。
  • 昼夜节律紊乱直接重编程NASH和肝癌转录组,驱动从肝癌发生到肝癌转移的快速进展。
  • 人肝细胞和肿瘤转录本与非实质细胞和肿瘤基质中的小鼠转录本可清晰区分,并在NASH中显示代谢、炎症、血管生成和致癌信号传导的动态变化,进展为肝细胞恶性转化和肝癌中的免疫抑制肿瘤基质。

临床怎么用

  • 作者指出,人源化肝脏小鼠为研究坏死炎症性肝脏环境和神经内分泌昼夜节律紊乱对肝癌发生及抗肝癌治疗的影响提供了有力的临床前模型。
  • 作者强调昼夜节律生物学在肝癌预防和治疗中的重要性。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Chronic circadian dysfunction increases the risk of non-alcoholic fatty liver disease (NAFLD)-related hepatocellular carcinoma (HCC), but the underlying mechanisms and direct relevance to human HCC have not been established. In this study, we aimed to determine whether chronic circadian dysregulation can drive NAFLD-related carcinogenesis from human hepatocytes and human HCC progression. METHODS: Chronic jet lag of mice with humanized livers induces spontaneous NAFLD-related HCCs from human hepatocytes. The clinical relevance of this model was analysed by biomarker, pathological/histological, genetic, RNA sequencing, metabolomic, and integrated bioinformatic analyses. RESULTS: Circadian dysfunction induces glucose intolerance, NAFLD-associated human HCCs, and human HCC metastasis independent of diet in a humanized mouse model. The deregulated transcriptomes in necrotic-inflammatory humanized livers and HCCs bear a striking resemblance to those of human non-alcoholic steatohepatitis (NASH), cirrhosis, and HCC. Stable circadian entrainment of hosts rhythmically paces NASH and HCC transcriptomes to decrease HCC incidence and prevent HCC metastasis. Circadian disruption directly reprogrammes NASH and HCC transcriptomes to drive a rapid progression from hepatocarcinogenesis to HCC metastasis. Human hepatocyte and tumour transcripts are clearly distinguishable from mouse transcripts in non-parenchymal cells and tumour stroma, and display dynamic changes in metabolism, inflammation, angiogenesis, and oncogenic signalling in NASH, progressing to hepatocyte malignant transformation and immunosuppressive tumour stroma in HCCs. Metabolomic analysis defines specific bile acids as prognostic biomarkers that change dynamically during hepatocarcinogenesis and in response to circadian disruption at all disease stages. CONCLUSION: Chronic circadian dysfunction is independently carcinogenic to human hepatocytes. Mice with humanized livers provide a powerful preclinical model for studying the impact of the necrotic-inflammatory liver environment and neuroendocrine circadian dysfunction on hepatocarcinogenesis and anti-HCC therapy. IMPACT AND IMPLICATIONS: Human epidemiological studies have linked chronic circadian dysfunction to increased hepatocellular carcinoma (HCC) risk, but direct evidence that circadian dysfunction is a human carcinogen has not been established. Here we show that circadian dysfunction induces non-alcoholic steatohepatitis (NASH)-related carcinogenesis from human hepatocytes in a murine humanized liver model, following the same molecular and pathologic pathways observed in human patients. The gene expression signatures of humanized HCC transcriptomes from circadian-disrupted mice closely match those of human HCC with the poorest prognostic outcomes, while those from stably circadian entrained mice match those from human HCC with the best prognostic outcomes. Our studies establish a new model for defining the mechanism of NASH-related HCC and highlight the importance of circadian biology in HCC prevention and treatment.

来源:J Hepatol,查看原文。版权归原作者所有。

引用

  1. Padilla J, Osman NM, Bissig-Choisat B, et al. Circadian dysfunction induces NAFLD-related human liver cancer in a mouse model. J Hepatol. 2023. PMID: 37890720. doi:10.1016/j.jhep.2023.10.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。